论文部分内容阅读
吡柔比星(Pirarubicin,THP)为新一代的蒽环类抗肿瘤药物,我们从1995年10月~1997年10月,应用以吡柔比星为主的联合化疗方案治疗各种儿童恶性肿瘤38例,并与同期应用表阿霉素为主的联合化疗治疗30例患儿作疗效及副作用比较,现报告如下...
Pirarubicin (THP) is a new generation of anthracycline antitumor drugs. From October 1995 to October 1997, we used a combination of pirarubicin-based chemotherapy in the treatment of various childhood malignancies 38 cases, and with the same period of epirubicin-based chemotherapy combined with 30 cases of children treated for efficacy and side effects, are reported as follows ...